Skip to content

    Recently Viewed

      Listening...

      What-Are-Autoantibodies-lede-1122.jpg

      What are autoantibodies?

      More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.

      Share Article
      share to

      Antibodies are proteins that guard against substances—such as bacteria, fungi, viruses and toxins—that enter your body like foreign invaders. Antibodies protect you by attaching to those invaders (also known as antigens) and triggering your body’s natural immune response to destroy them.

      You can think of autoantibodies as misguided, or pathogenic, antibodies. Instead of reacting to the antigen, they respond to your body’s own proteins, leading—in some cases—to an abnormal immune response that attacks the cells, tissues and organs of your body and contributes to the development of autoantibody diseases.
      “Autoantibody diseases comprise a large and varied group of more than 80 chronic conditions,” says Katie Abouzahr, Vice President, Autoantibody Portfolio Development Leader, Janssen Research and Development. They include hemolytic disease of the fetus and newborn, in which a mother’s immune system attacks her unborn child’s blood cells; warm autoimmune hemolytic anemia, which involves the premature destruction of healthy red blood cells; and myasthenia gravis, a disorder that’s characterized by fluctuating weakness in the skeletal muscles.

      Autoantibodies can be markers of autoimmune diseases like rheumatoid arthritis or lupus. In fact, more than 2.5% of the population is affected by an autoantibody-driven autoimmune disease.

      “Autoantibody diseases represent a significant area of unmet patient need,” says Abouzahr. “There are 240 million people worldwide, approximately 3% of the population, who suffer from autoantibody diseases, many without safe and effective treatment options.”

      That’s why Johnson & Johnson is working on immunological advances to help address the need.

      Watch this video to learn more about autoantibodies and their role in rare diseases:

      Are You Affected by an Autoantibody Disease?

      Learn more about two clinical research studies and eligibility requirements.

      More from Johnson & Johnson

      Health & wellness
      PsaQuizLede.jpeg
      Health & wellness

      Quiz: How much do you know about psoriasis?

      The chronic skin condition causes itchy and scaly patches, but it’s much more than simply a cosmetic concern. For World Psoriasis Day, take this quiz to test your psoriasis IQ—and learn why Johnson & Johnson is working on new and more effective treatments for this common autoimmune disease.
      Health & wellness
      What It's Like When Your Baby Has a Rare Blood Disorder-1023.jpg
      Health & wellness

      What it’s like when your baby has a rare blood disorder

      A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.
      Health & wellness
      Imaging  of stroke
      Health & wellness

      Inside the science of strokes

      Strokes are responsible for around 140,000 deaths a year in the United States alone. For World Stroke Day, learn how Johnson & Johnson is innovating to help change that stat.
      You are now leaving JNJ.com and going to a site with a different privacy policy. Please click below to continue to that site.